← 返回专利悬崖列表
甲磺酸兰泽替尼
Tier C · 观察 / 贸易Lazertinib Mesylate
Oscotec Inc
原研
2021
首批上市
-
到期年(公开口径)
无销量数据
峰值销售
化学药
类型
靶点:EGFR T790M、EGFR L858R、EGFR 19del、VEGFR
商品名:利珂、Lazcluze、Leclaza
适应症(已批准):非小细胞肺癌
各地区研发/上市状态
美国
批准上市
2024-08-20
欧盟
批准上市
2025-01-20
中国
批准上市
2025-07-29
日本
批准上市
2025-03-27
合成路线与中间体5 routes
原研路线 × 1优化路线(非专利)× 4工艺路线 × 0
路线按「原研路线 → 优化路线 / 工艺路线(非专利)」排序。每条路线附本站自绘的路线流程图(中间体 → 原料药)与中间体表(编号 / CAS / 英文名),可直接用于供应商开发与询价。流程图由本站依据已授权的结构化数据自行渲染,未使用任何第三方路线图。
原研Route 1步骤 5 · 总收率 /
(I) 920279-1-a1075705-01-9(II) 920279-1-a—(III) 920279-1-a1903010-37-6(IV) 920279-1-a110-91-8(V) 920279-1-a1903010-39-8(VI) 920279-1-a—(VII) 920279-1-a1903009-55-1(VIII) 920279-1-a1903009-56-2(IX) 920279-1-a814-68-6(X) 920279-1-a—API · 甲磺酸兰泽替尼
| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| (I) 920279-1-a | 1075705-01-9在售 | 2-Amino-5-fluoro-4-nitroanisole |
| (II) 920279-1-a | - | 1-(2-Iodopyrimidin-4-yl)-3-phenyl-1H-pyrazole-4-carbaldehyde |
| (III) 920279-1-a | 1903010-37-6在售 | 1-[2-(4-Fluoro-2-methoxy-5-nitroanilino)pyrimidin-4-yl]-3-phenyl-1H-pyrazole-4-carbaldehyde |
| (IV) 920279-1-a | 110-91-8在售 | 1-Oxa-4-azacyclohexane |
| (V) 920279-1-a | 1903010-39-8在售 | 1-[2-[2-Methoxy-4-(morpholin-4-yl)-5-nitroanilino]pyrimidin-4-yl]-3-phenyl-1H-pyrazole-4-carbaldehyde |
| (VI) 920279-1-a | - | Dimethylamine anhydrous |
| (VII) 920279-1-a | 1903009-55-1在售 | 4-[4-[(Dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]-N-[2-methoxy-4-(morpholin-4-yl)-5-nitrophenyl]pyrimidin-2-amine |
| (VIII) 920279-1-a | 1903009-56-2在售 | N1-[4-[4-[(Dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]pyrimidin-2-yl]-6-methoxy-4-(morpholin-4-yl)benzene-1,3-diamine |
| (IX) 920279-1-a | 814-68-6在售 | 2-Propenoyl chloride; Acrylic acid chloride; Acrylic chloride; Acryloyl chloride |
| (X) 920279-1-a | - | N-[5-[(4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl]prop-2-enamide |
优化Route 2步骤 8 · 总收率 /
(I) 920279-2-a1075705-01-9(II) 920279-2-a1802924-13-5(III) 920279-2-a110-91-8(IV) 920279-2-a2226199-40-0(V) 920279-2-a2226198-97-4(VI) 920279-2-a625-36-5(VII) 920279-2-a2270204-97-0(VIII) 920279-2-a2226388-61-8(IX) 920279-2-a2226199-23-9(X) 920279-2-a,(X) 920279-2-b1903010-38-7(XI) 920279-2-a2270204-98-1(XII) 920279-2-a506-59-2(XIII) 920279-2-a—API · 甲磺酸兰泽替尼
| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| (I) 920279-2-a | 1075705-01-9在售 | 2-Amino-5-fluoro-4-nitroanisole |
| (II) 920279-2-a | 1802924-13-5在售 | N-Boc-4-Fluoro-2-methoxy-5-nitroaniline |
| (III) 920279-2-a | 110-91-8在售 | 1-Oxa-4-azacyclohexane |
| (IV) 920279-2-a | 2226199-40-0在售 | N-Boc-2-Methoxy-4-morpholin-4-yl-5-nitroaniline |
| (V) 920279-2-a | 2226198-97-4在售 | tert-Butyl [5-amino-2-methoxy-4-(morpholin-4-yl)phenyl]carbamate |
| (VI) 920279-2-a | 625-36-5在售 | (Chloromethyl)acetyl chloride |
| (VII) 920279-2-a | 2270204-97-0在售 | tert-Butyl [5-(3-chloropropanamido)-2-methoxy-4-(morpholin-4-yl)phenyl]carbamate |
| (VIII) 920279-2-a | 2226388-61-8在售 | N-(5-N-Boc-Amino-4-methoxy-2-morpholin-4-ylphenyl)acrylamide |
| (IX) 920279-2-a | 2226199-23-9在售 | N-[5-Amino-4-methoxy-2-(morpholin-4-yl)phenyl]prop-2-enamide |
| (X) 920279-2-a,(X) 920279-2-b | 1903010-38-7在售 | 1-(2-Chloropyrimidin-4-yl)-3-phenyl-1H-pyrazole-4-carbaldehyde |
| (XI) 920279-2-a | 2270204-98-1在售 | N-[5-[[4-(4-Formyl-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl]amino]-4-methoxy-2-(morpholin-4-yl)phenyl]prop-2-enamide |
| (XII) 920279-2-a | 506-59-2在售 | Dimethylamine hydrochloride |
| (XIII) 920279-2-a | - | N-[5-[(4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl]prop-2-enamide |
优化Route 3步骤 1 · 总收率 /
(X) 920279-2-a,(X) 920279-2-b1903010-38-7(XIV) 920279-2-b3934-20-1(XV) 920279-2-b26033-20-5API · 甲磺酸兰泽替尼
| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| (X) 920279-2-a,(X) 920279-2-b | 1903010-38-7在售 | 1-(2-Chloropyrimidin-4-yl)-3-phenyl-1H-pyrazole-4-carbaldehyde |
| (XIV) 920279-2-b | 3934-20-1在售 | 2-Chloropyrimidin-4-yl chloride |
| (XV) 920279-2-b | 26033-20-5在售 | 3-Phenyl-1H-pyrazole-4-carbaldehyde |
优化Route 4步骤 7 · 总收率 /
(I) 920279-3-a1075705-01-9(II) 920279-3-a110-91-8(III) 920279-3-a1903010-18-3(IV) 920279-3-a1903009-70-0(V) 920279-3-a2270865-21-7(VI) 920279-3-a625-36-5(VII) 920279-3-a2270865-25-1(VIII) 920279-3-a2270865-24-0(IX) 920279-3-a2270865-23-9(X) 920279-3-a2270204-98-1(XI) 920279-3-a506-59-2(XII) 920279-3-a—(XIII) 920279-3-a26033-20-5(XIV) 920279-3-a49844-90-8(XV) 920279-3-a2270865-22-8API · 甲磺酸兰泽替尼
| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| (I) 920279-3-a | 1075705-01-9在售 | 2-Amino-5-fluoro-4-nitroanisole |
| (II) 920279-3-a | 110-91-8在售 | 1-Oxa-4-azacyclohexane |
| (III) 920279-3-a | 1903010-18-3在售 | 2-Methoxy-4-(morpholin-4-yl)-5-nitroaniline |
| (IV) 920279-3-a | 1903009-70-0在售 | 2-Methoxy-4-morpholin-4-yl-5-nitrophenylformamide |
| (V) 920279-3-a | 2270865-21-7在售 | 5-Amino-2-methoxy-4-morpholin-4-ylphenylformamide |
| (VI) 920279-3-a | 625-36-5在售 | (Chloromethyl)acetyl chloride |
| (VII) 920279-3-a | 2270865-25-1在售 | 3-Chloro-N-[5-formamido-4-methoxy-2-(morpholin-4-yl)phenyl]propanamide |
| (VIII) 920279-3-a | 2270865-24-0在售 | N-[5-(Formylamino)-4-methoxy-2-morpholin-4-ylphenyl]acrylamide |
| (IX) 920279-3-a | 2270865-23-9在售 | 1-[2-(Methanesulfonyl)pyrimidin-4-yl]-3-phenyl-1H-pyrazole-4-carbaldehyde |
| (X) 920279-3-a | 2270204-98-1在售 | N-[5-[[4-(4-Formyl-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl]amino]-4-methoxy-2-(morpholin-4-yl)phenyl]prop-2-enamide |
| (XI) 920279-3-a | 506-59-2在售 | Dimethylamine hydrochloride |
| (XII) 920279-3-a | - | N-[5-[(4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl]prop-2-enamide |
| (XIII) 920279-3-a | 26033-20-5在售 | 3-Phenyl-1H-pyrazole-4-carbaldehyde |
| (XIV) 920279-3-a | 49844-90-8在售 | 4-Chloro-2-(methylsulfanyl)pyrimidine |
| (XV) 920279-3-a | 2270865-22-8在售 | 1-[2-(Methylsulfanyl)pyrimidin-4-yl]-3-phenyl-1H-pyrazole-4-carbaldehyde |
优化Route 5步骤 7 · 总收率 /
(I) 920279-4-a49844-90-8(II) 920279-4-a97229-11-3(III) 920279-4-a1903009-70-0(IV) 920279-4-a2270944-70-0(V) 920279-4-a26033-20-5(VI) 920279-4-a1903010-39-8(VII) 920279-4-a2270865-23-9(VIII) 920279-4-a506-59-2(IX) 920279-4-a1903009-55-1(X) 920279-4-a1903009-56-2(XIa) 920279-4-a625-36-5(XIb) 920279-4-a15486-96-1(XIIa) 920279-4-a2270944-72-2(XIIb) 920279-4-a2270944-73-3(XIII) 920279-4-a—API · 甲磺酸兰泽替尼
| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| (I) 920279-4-a | 49844-90-8在售 | 4-Chloro-2-(methylsulfanyl)pyrimidine |
| (II) 920279-4-a | 97229-11-3在售 | 4-Chloro-2-(methanesulfonyl)pyrimidine |
| (III) 920279-4-a | 1903009-70-0在售 | 2-Methoxy-4-morpholin-4-yl-5-nitrophenylformamide |
| (IV) 920279-4-a | 2270944-70-0在售 | 4-Chloro-N-[2-methoxy-4-(morpholin-4-yl)-5-nitrophenyl]pyrimidin-2-amine |
| (V) 920279-4-a | 26033-20-5在售 | 3-Phenyl-1H-pyrazole-4-carbaldehyde |
| (VI) 920279-4-a | 1903010-39-8在售 | 1-[2-[2-Methoxy-4-(morpholin-4-yl)-5-nitroanilino]pyrimidin-4-yl]-3-phenyl-1H-pyrazole-4-carbaldehyde |
| (VII) 920279-4-a | 2270865-23-9在售 | 1-[2-(Methanesulfonyl)pyrimidin-4-yl]-3-phenyl-1H-pyrazole-4-carbaldehyde |
| (VIII) 920279-4-a | 506-59-2在售 | Dimethylamine hydrochloride |
| (IX) 920279-4-a | 1903009-55-1在售 | 4-[4-[(Dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]-N-[2-methoxy-4-(morpholin-4-yl)-5-nitrophenyl]pyrimidin-2-amine |
| (X) 920279-4-a | 1903009-56-2在售 | N1-[4-[4-[(Dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]pyrimidin-2-yl]-6-methoxy-4-(morpholin-4-yl)benzene-1,3-diamine |
| (XIa) 920279-4-a | 625-36-5在售 | (Chloromethyl)acetyl chloride |
| (XIb) 920279-4-a | 15486-96-1在售 | 3-Bromopropanoyl chloride |
| (XIIa) 920279-4-a | 2270944-72-2在售 | 3-Chloro-N-[5-[(4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl]propanamide |
| (XIIb) 920279-4-a | 2270944-73-3在售 | 3-Bromo-N-[5-[(4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl]propanamide |
| (XIII) 920279-4-a | - | N-[5-[(4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl]prop-2-enamide |
常见问题(FAQ)
甲磺酸兰泽替尼的适应症有哪些?
已批准的适应症包括:非小细胞肺癌。
甲磺酸兰泽替尼的专利什么时候到期?
甲磺酸兰泽替尼的专利到期年暂无公开口径,本页会在数据管道核实后更新。
甲磺酸兰泽替尼有几条合成路线?
本站收录 5 条合成路线,最短路线 1 步、总收率 /。每条路线的中间体均带登记编号与 CAS 号。
甲磺酸兰泽替尼的关键中间体在哪里可以采购?
甲磺酸兰泽替尼的多条路线中间体已挂接 CAS 档案,其中 32 个 CAS 已有优贝德(Unibest)供应网络在售报价,可在本页路线表中直接查看并询价。
如何获取甲磺酸兰泽替尼中间体的报价?
在本页选择目标中间体的 CAS 进入档案页,或在询价页直接提交需求;CAS 会自动带入供需撮合流程,由供应网络反馈报价。
数据来源:多源数据交叉核实(仅结构化字段) · 2026-10-22